Bluebird Bio reported $247.76M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acceleron Pharma XLRN:US $ 59.48M 9.66M
Agios Pharmaceuticals AGIO:US $ 60.65M 35.85M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
Alnylam Pharmaceuticals ALNY:US $ 554.65M 59.82M
Amgen AMGN:US $ 14585M 1716M
Applied Genetic Technologies AGTC:US $ 19.71M 3.16M
Arrowhead Research ARWR:US $ 195.43M 28.25M
Avrobio Inc AVRO:US $ 16.95M 4.18M
Biogen BIIB:US $ 3347.2M 181.4M
Biomarin Pharmaceutical BMRN:US $ 443.34M 13.31M
Bluebird Bio BLUE:US $ 247.76M 41.45M
Dicerna Pharmaceuticals DRNA:US $ 207.65M 25.5M
Gilead Sciences GILD:US $ 10214M 509M
Immunogen IMGN:US $ 120.32M 14.03M
Intercept Pharmaceuticals ICPT:US $ 145.28M 0.95M
IONIS PHARMACEUT IONS:US $ 293.82M 1.28M
Mirati Therapeutics MRTX:US $ 180.87M 103.76M
Moderna Inc MRNA:US 8.84B 399M
Nektar Therapeutics NKTR:US $ 131.02M 7.39M
Novartis NOVN:VX SF 29633M 527M
Ptc Therapeutics PTCT:US $ 290.96M 40.01M
Regeneron Pharmaceuticals REGN:US $ 3732.4M 514.6M
Sangamo Biosciences SGMO:US $ 136.94M 4.1M
Sarepta Therapeutics SRPT:US $ 425.02M 60.29M
Seattle Genetics SGEN:US $ 433.83M 44.22M
Ultragenyx Pharmaceutical RARE:US $ 127.07M 0.02M
Vertex Pharmaceuticals VRTX:US $ 1836.45M 107.6M
YTE INCY:US $ 660.32M 36.44M